Hemostemix Inc. is a biotech company situated in Calgary, Canada, headed by Thomas A. Smeenk. The company manages the exploration, improvement, and assembling of inventive blood-derived stem cell therapies with marvelous recuperating and recovery properties bringing about less immunogenic variables.